“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms

• Hélène F.E. Gleitz,
• Rebekka K. Schneider

Affiliations

Hélène F.E. Gleitz

Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam

Rebekka K. Schneider

Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cell Biology, Faculty of Medicine, Institute for Biomedical Engineering, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen